✦ LIBER ✦

Disparities in death certificates of Parkinson's disease patients: A report from a population of brain donors

✍ Scribed by Spiridon Papapetropoulos; Jose M. Villar; Jocely Gonzalez; Deborah C. Mash

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 46 KB
Volume: 21
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.20832

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply: Disparities in death certificates

Reply: Disparities in death certificates of Parkinson's disease patients

✍ Joyce C. Pressley 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB 👁 1 views

The present study has several limitations, with its retrospective nature, the selected sample of brain donors, and the small number of patients being the most important. Although PD reporting in death certificate may be increasing, our results are in agreement with those of previous studies and sug

Dementia in Parkinson's disease: a post-

Dementia in Parkinson's disease: a post-mortem study in a population of brain donors

✍ S. Papapetropoulos; J. Gonzalez; A. Lieberman; J. M. Villar; D. C. Mash 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB 👁 1 views

## Abstract ## Objective To identify factors associated with dementia in a cohort of Parkinson's disease (PD) brain donors and determine whether its presence may influence the clinical phenotype of the disease. ## Methods We included 67 consecutive patients with a clinical and pathological diagn

Rimantadine in Parkinson's disease patie

Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: Report of a case series

✍ Carlos Singer; Spiridon Papapetropoulos; Manuel A. Gonzalez; Eugene L. Roberts; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

## Abstract We report our experience with 7 consecutive patients with Parkinson's disease (PD) who received rimantadine (the α‐methyl derivative of amantadine) in substitution of amantadine due to peripheral side effects (lower limb edema, livedo reticularis). Mean age was 67.3 ± 5.9 years, the mea

Essential tremor in Parkinson's disease

Essential tremor in Parkinson's disease kindreds from a population of similar genetic background

✍ Cleanthe Spanaki; Andreas Plaitakis 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 1 views

## Abstract To investigate the possible association between essential tremor (ET) and Parkinson's disease (PD) we conducted a prospective clinical and epidemiological study in a population of similar genetic background. The first‐degree relatives of 303 PD probands and 249 controls from Crete were

Test–Retest reliability of the Unified P

Test–Retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: Results from a multicenter clinical trial

✍ Andrew Siderowf; Michael McDermott; Karl Kieburtz; Karen Blindauer; Sandra Plumb 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

Our objective was to assess the test-retest reliability of the Unified Parkinson's Disease Rating Scale (UPDRS). The UPDRS is the most widely used instrument for measuring severity of parkinsonian symptoms in clinical research and in practice. The validity and inter-rater reliability of this scale h

Survival time, mortality, and cause of d

Survival time, mortality, and cause of death in elderly patients with Parkinson's disease. A 9-year follow-up

✍ Per-Arne Fall; Avin Saleh; Mats Fredrickson; Jan-Edvin Olsson; Ann-Kathrine Gran 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

## Abstract This community‐based study of Parkinson's disease (PD) investigated age at death and cause of death in a cohort of 170 previously studied patients. The current study is a 9‐year follow‐up, and the results are compared to 510 sex‐ and age‐matched controls from the same area. A total of 1